{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.202.202",
    "article_title": "Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms ",
    "article_date": "December 7, 2017",
    "session_type": "634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant",
    "abstract_text": "BACKGROUND. Very few previous studies have estimated the risk of recurrence after cerebral transient ischemic attack (TIA) or ischemic stroke (IS) in patients with myeloproliferative neoplasms (MPN). PRISM (Preventing Ischemic Stroke in Myeloproliferative Neoplasms) is an international investigator-driven study with three purposes: (1) to describe the clinical profile at presentation of ischemic TIA/IS in contemporary patients with polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF); (2) to evaluate the short and long-term outcomes beyond the acute phase and to explore their comparability with non MPN population; (3) to refine the risk assessment for recurrences and cardiovascular mortality. METHODS. From January 2005 through December 2015, 597 patients with objectively proven TIA (n= 270) or IS (n=327) at 22 sites of 5 countries were enrolled. We estimated the 1- and 5-year risk of composite cardiovascular (CV) outcome, including recurrent TIA, IS, myocardial infarction (AMI) and CV deaths, and analyzed the incidence of each single outcome by competing risk method. RESULTS. The distribution of single MPN and baseline blood counts were similar in IS and TIA groups; atrial fibrillation was observed in a minority of cases (4% TIA and 7% IS) as compared with the general population (11-18% and 20%-30%, respectively); other comorbidities were approximately half of those of non-MPN patients [ Weimar C et al, Arch Neurol 2002;59:1584; Buchwald F et al, Stroke 2016;47:2456; Amarenco P et al, N Engl J Med 2016;374:1533 ]; a substantial proportion of TIA cases had a higher history of microvascular disturbances while arterial hypertension was more frequent in IS than TIA. Secondary prophylaxis included aspirin, oral anticoagulants and cytoreductive therapy. After one year since the TIA index event, the incidence of cumulative outcome was 4.21%. However, no IS happened in the first 2 years after TIA and this event after 5 years happened in only 1.24% of cases. The corresponding incidence in the general population was 4.4% to 5.1% after one year and 12-16% after 5 years [ Weimar C et al, Arch Neurol 2002;59:1584; Buchwald F et al, Stroke 2016;47:2456; Amarenco P et al, N Engl J Med 2016;374:1533 ]. In contrast, new TIA episodes progressively increased year by year reaching 12% incidence after 5 years. After the IS index event, new strokes occurred with cumulative incidence lower than in the general population: after 1 and 5 years, the incidence was 2.03% and 6.52% vs 11.1%-12% and 26.4% of non-MPN patients [ Mohan KM et al, Stroke 2011;42:1489; Bergstrom L et al, Stroke 2017 Jul 13, AOP ]. The rate of deep venous thrombosis (DVT) in the first year, was higher after index IS than TIA, but was the same by 5 years (3.68% and 4.60%, respectively; p=0.47). Predictors of recurrent TIA and IS were the same index events (HR=2.41 and 4.41), and for recurrent TIA the remote history of cerebrovascular TIA episodes (HR=3.40) and microvascular disturbances (HR=2.30). Other prognostic factors of recurrent IS were arterial hypertension (HR=4.24) and occurrence of IS during the course of MPN (HR=4.27). On the contrary, cytoreductive therapy emerged as a strong protective factor able to reduce the probability of new strokes in 76% of patients (HR=0.24). The history of peripheral thrombosis, both venous and arterial events, independently predicted the occurrence of AMI (HR=6.30), while age over 60 years (HR=3.98), index IS (HR=3.61), occurrence after MPN diagnosis (HR=2.62), were all prognostically significant for CV mortality. During median follow-up of 4.2 years, major bleeding occurred with a frequency similar to that observed in the general population receiving long-term antiplatelet secondary prophylaxis (0.90 % pts/year) [ Li L et al, Lancet 2017 Jun 13, AOP ]. CONCLUSION. Current antithrombotic therapy and cytoreductive drugs after index TIA and IS led to a reduction of cardio-vascular recurrences and mortality in a proportion of MPN patients greater than in general population. This would indicate that ischemic cerebral vascular events recognize a specific pathogenesis of thrombosis linked to the clonal disorder. Although the benefit-risk profile of secondary prophylaxis appears favorable, some high risk categories need new intervention strategies to be defined in prospective studies. Disclosures Iurlo: Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria. Finazzi: Italfarmaco S.p.A.: Consultancy. Bonifacio: Incyte: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Pfizer: Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees. Gaidano: Gilead: Consultancy, Honoraria; Roche: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; AbbVie: Consultancy, Honoraria; Janssen: Consultancy, Honoraria. Vannucchi: Shire: Speakers Bureau; Novartis: Honoraria, Speakers Bureau.",
    "topics": [
        "cardiovascular event",
        "ischemic stroke",
        "myeloproliferative disease",
        "transient ischemic attack",
        "cerebrovascular accident",
        "apnea of prematurity",
        "cytoreductive therapy",
        "deep vein thrombosis",
        "hypertension",
        "ischemia"
    ],
    "author_names": [
        "Tiziano Barbui, MD",
        "Valerio De Stefano, MD",
        "Alessandra Carobbio, MSc",
        "Vincenzo Di Lazzaro, MD",
        "Paola Guglielmelli, MD PhD",
        "Giuseppe Gaetano Loscocco, MD",
        "Alessandra Iurlo, MD PhD",
        "Daniele Cattaneo, MD",
        "Agostino Cortelezzi, Prof",
        "Silvia Betti, MD",
        "Elena Rossi, MD",
        "Maria Chiara Finazzi, MD",
        "Guido Finazzi, MD",
        "Bruno Censori, MD",
        "Mario Cazzola, MD",
        "Elisa Rumi, MD",
        "Marta Bellini, MD",
        "Francisco Cervantes, MD",
        "Eduardo Arellano-Rodrigo, MD",
        "Elena Elli, MD",
        "Maria Luigia Randi, MD",
        "Irene Bertozzi, MD",
        "Martin Griesshammer, MD",
        "Parvis Sadjadian, MD",
        "Francesca Palandri, PhD MD",
        "Nicola Vianelli",
        "Massimiliano Bonifacio, MD",
        "Luigi Scaffidi",
        "Juan Carlos Hernandez-Boluda, MD",
        "Montse Gomez, MD",
        "Emma Cacciola, MD",
        "Rossella Rosari Cacciola, MD",
        "Palova Miroslava, MD",
        "Giuseppe Carli, MD",
        "Eloise Beggiato, MD",
        "Martin H Ellis, MD",
        "Caterina Musolino, MD",
        "Gianluca Gaidano, MD PhD",
        "Davide Rapezzi, MD",
        "Alessia Tieghi, MD",
        "Francesca Lunghi, MD",
        "Alessandro M. Vannucchi"
    ],
    "author_dict_list": [
        {
            "author_name": "Tiziano Barbui, MD",
            "author_affiliations": [
                "FROM Research Foundation Bergamo, Bergamo, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Valerio De Stefano, MD",
            "author_affiliations": [
                "Hematology, Catholic University, Rome, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Carobbio, MSc",
            "author_affiliations": [
                "FROM Research Foundation Bergamo, Bergamo, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Di Lazzaro, MD",
            "author_affiliations": [
                "Clinical Neurology, Campus Biomedico, University of Rome, Rome, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paola Guglielmelli, MD PhD",
            "author_affiliations": [
                "CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Gaetano Loscocco, MD",
            "author_affiliations": [
                "CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Iurlo, MD PhD",
            "author_affiliations": [
                "Hematology Division, IRCCS C\u00e0 Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniele Cattaneo, MD",
            "author_affiliations": [
                "Hematology Division, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Milan, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Agostino Cortelezzi, Prof",
            "author_affiliations": [
                "University of Milan, Milan, Italy ",
                "Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico e Universit\u00e0 degli Studi di Milano, Milano, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Silvia Betti, MD",
            "author_affiliations": [
                "Hematology, Catholic University, Rome, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elena Rossi, MD",
            "author_affiliations": [
                "Hematology, Catholic University, Rome, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Chiara Finazzi, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplant Unit, Papa Giovanni XXIII hospital, Bergamo, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Finazzi, MD",
            "author_affiliations": [
                "Hematology and Bone Marrow Transplant Unit, Papa Giovanni XXIII hospital, Bergamo, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bruno Censori, MD",
            "author_affiliations": [
                "Neurology, Papa Giovanni XXIII hospital, Bergamo, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Cazzola, MD",
            "author_affiliations": [
                "Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisa Rumi, MD",
            "author_affiliations": [
                "Departments of Hematology Oncology & Molecular Medicine, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Bellini, MD",
            "author_affiliations": [
                "Department of Molecular Medicine, University of Pavia, Pavia, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francisco Cervantes, MD",
            "author_affiliations": [
                "Hospital Clinic, Barcelona, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eduardo Arellano-Rodrigo, MD",
            "author_affiliations": [
                "Hospital Clinic, Barcelona, Spain "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elena Elli, MD",
            "author_affiliations": [
                "Hematology, San Gerardo Hospital, Monza, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Luigia Randi, MD",
            "author_affiliations": [
                "Department of Medicine - DIMED, University of Padua, Padua, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Irene Bertozzi, MD",
            "author_affiliations": [
                "Department of Medicine - DIMED, University of Padua, Padua, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martin Griesshammer, MD",
            "author_affiliations": [
                "University Clinic for Hematology and Oncology Minden, University of Bochum, Minden, Germany "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Parvis Sadjadian, MD",
            "author_affiliations": [
                "University Clinic for Hematology and Oncology Minden, University of Bochum, Minden, Germany "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Palandri, PhD MD",
            "author_affiliations": [
                "Institute of Hematology \"L. and A. Ser\u00e0gnoli\", Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy ",
                "Department of Hematology/Oncology, Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicola Vianelli",
            "author_affiliations": [
                "Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \"L. and A. Ser\u00e0gnoli\", Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimiliano Bonifacio, MD",
            "author_affiliations": [
                "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigi Scaffidi",
            "author_affiliations": [
                "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan Carlos Hernandez-Boluda, MD",
            "author_affiliations": [
                "Hematology Department, Hospital Cl\u00ednico Universitario, Valencia, Spain "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Montse Gomez, MD",
            "author_affiliations": [
                "Hematology Department, Hospital Cl\u00ednico Universitario, Valencia, Spain "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emma Cacciola, MD",
            "author_affiliations": [
                "Department of Medical, Surgical and Advance Technologies Sciences \"G..F. Ingrassia\", University of Catania, A.O.U. \"Policlinico-Vittorio Emanuele\", Catania, Italy "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rossella Rosari Cacciola, MD",
            "author_affiliations": [
                "Department of Clinical and Experimental Medicine, University of Catania, A.O.U. \"Policlinico-Vittorio Emanuele\", Catania, Italy "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Palova Miroslava, MD",
            "author_affiliations": [
                "Dept. Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Carli, MD",
            "author_affiliations": [
                "U.O. Ematologia, Ospedale San Bortolo di Vicenza, Vicenza, Italy "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eloise Beggiato, MD",
            "author_affiliations": [
                "Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martin H Ellis, MD",
            "author_affiliations": [
                "Hematology Institute and Blood Bank, Meir Medical Center, Kfar Saba, Israel ",
                "Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Musolino, MD",
            "author_affiliations": [
                "Section of Hematology, A.O.U. Policlinico, Messina, Italy "
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gianluca Gaidano, MD PhD",
            "author_affiliations": [
                "Amedeo Avogadro University of Eastern Piedmont, Novara, Italy "
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Davide Rapezzi, MD",
            "author_affiliations": [
                "S.C. Ematologia, ASO S. Croce e Carle, Cuneo, Italy "
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Tieghi, MD",
            "author_affiliations": [
                "Ematologia, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy "
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Lunghi, MD",
            "author_affiliations": [
                "U.O. Ematologia e Trapianto di Midollo Osseo, Ospedale San Raffaele IRCCS, Milan, Italy "
            ],
            "author_rank": 41,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro M. Vannucchi",
            "author_affiliations": [
                "Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy"
            ],
            "author_rank": 42,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-09T21:38:05",
    "is_scraped": "1"
}